跳至主要内容
临床试验/JPRN-UMIN000002144
JPRN-UMIN000002144已完成未知

A clinical study of amlodipine besilate OD tablet for the essential hypertension patients - Comparative study on the antihypertensive effect and the safety between a bland drug and a generic drug - - A comparative study on the efficacy and safety between a bland drug and a generic drug of the amlodipine besilate OD tablet

agano Kidney Evaluation Association (NKEA)0 个研究点目标入组 100 人开始时间: 2009年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients who take calcium channel blocker except amlodipine besilate regular tablets 2.Grade III hypertension 3.Secondary hypertension 4.Malignant hypertension 5.Patients with hepatic dysfunction or severe hepatic disease 6.Patients with a past history of hypersensitiveness to the study drug 7.Pregnant, lactating, and probably pregnant patients, and patients who want to become pregnant during the study period 8.Patients with malignant cancer 9.Patients with a past history of drug abuse or drug addiction 10.Patients who have attended toany clinical trials within 12 months before the start of the administration, etc

研究者

发起方
agano Kidney Evaluation Association (NKEA)

相似试验